medigraphic.com
ENGLISH

Revista Mexicana de Medicina Transfusional

ISSN 2007-6509 (Impreso)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2026, Número S1

<< Anterior Siguiente >>

Rev Mex Med Transfus 2026; 18 (S1)


Platelet transfusion refractoriness: diagnosis and management

Cohn CS
Texto completo Cómo citar este artículo 10.35366/124197

DOI

DOI: 10.35366/124197
URL: https://dx.doi.org/10.35366/124197

Idioma: Español
Referencias bibliográficas: 5
Paginas: 97-99
Archivo PDF: 126.95 Kb.


PALABRAS CLAVE

Sin palabras Clave

FRAGMENTO

Introduction Platelet transfusion refractoriness is a repeated suboptimal response to platelet transfusion, manifested by lower-than-expected posttransfusion platelet count increments. The first tasks are to confirm that the patient is truly refractory and to determine whether the cause is non-immune, immune, or a combination of both. Non-immune factors account for most cases, whereas immune-mediated refractoriness is less common but requires specialized testing and platelet selection.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Davis KB, Slichter SJ, Corash L. Corrected count increment andpercent platelet recovery as measures of posttransfusion plateletresponse: problems and a solution. Transfusion. 1999; 39 (6): 586-592. doi: 10.1046/j.1537-2995.1999.39060586.x.

  2. Stanworth SJ, Navarrete C, Estcourt L, Marsh J. Plateletrefractoriness—practical approaches and ongoing dilemmas inpatient management. Br J Haematol. 2015; 171 (3): 297-305. doi:10.1111/bjh.13597.

  3. Legler TJ, Fischer I, Dittmann J, Simson G, Lynen R, HumpeA et al. Frequency and causes of ref ractoriness in multiplytransfused patients. Ann Hematol. 1997;74(4):185-189. doi: 10.1007/s002770050280.

  4. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, KaoKJ et al. Factors affecting posttransfusion platelet increments,platelet refractoriness, and platelet transfusion intervals inthrombocytopenic patients. Blood. 2005; 105 (10): 4106-4114. doi:10.1182/blood-2003-08-2724.

  5. Kickler TS, Kennedy SD, Braine HG. Alloimmunization to plateletspecificantigens on glycoproteins IIb-IIIa and Ib/IX in multiplytransfused thrombocytopenic patients. Transfusion. 1990; 30 (7): 622-625. doi: 10.1046/j.1537-2995.1990.30790385520.x.




CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Med Transfus. 2026;18

ARTíCULOS SIMILARES

CARGANDO ...